NasdaqCM - Delayed Quote USD

Guardion Health Sciences, Inc. (GHSI)

9.90 +0.15 (+1.54%)
At close: June 7 at 4:00 PM EDT
9.75 -0.15 (-1.52%)
After hours: June 7 at 4:29 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Robert Neal Weingarten Independent Chairman & Secretary 110k -- 1952
Ms. Janet Hall President & CEO 704.85k -- 1959
Ms. Katie Cox Chief Accounting Officer 275k -- 1970
Mr. Craig J. Sheehan Chief Commercial Officer 457.5k -- 1971

Guardion Health Sciences, Inc.

2925 Richmond Avenue
Suite 1200
Houston, TX 77098
United States
800 873 5141 https://www.guardionhealth.com
Sector: 
Healthcare
Full Time Employees: 
9

Description

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Corporate Governance

Guardion Health Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 12, 2024 at 12:30 PM UTC - August 16, 2024 at 12:30 PM UTC

Guardion Health Sciences, Inc. Earnings Date

Recent Events

June 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 23, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 21, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 13, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 2, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 1, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

April 29, 2024 at 12:00 AM UTC

10-K/A: Periodic Financial Reports

April 9, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 8, 2024 at 12:00 AM UTC

DEFM14A: Proxy Statements

Related Tickers